Early research (Phase 1)Study completedNCT01233895What this trial is testingStudy of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple MyelomaWho this might be right forMultiple Myeloma Sanofi 26
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Early research (Phase 1)Ended earlyNCT02082977What this trial is testingInvestigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple MyelomaWho this might be right forCancerNeoplasms GlaxoSmithKline 41
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060627What this trial is testingStudy of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to LenalidomideWho this might be right forRelapsed Multiple Myeloma PETHEMA Foundation 60
Testing effectiveness (Phase 2)Ended earlyNCT03457142What this trial is testingAbatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to ChemotherapyWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma Roswell Park Cancer Institute 15
Early research (Phase 1)Ended earlyNCT03755154What this trial is testingStudy of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic LeukemiaWho this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more Institut de Recherches Internationales Servier 60
Testing effectiveness (Phase 2)Ended earlyNCT00790842What this trial is testingLenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney DysfunctionWho this might be right forMultiple MyelomaPlasma Cell Neoplasm PrECOG, LLC. 63
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07518186What this trial is testingA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 700
Testing effectiveness (Phase 2)Study completedNCT00229203What this trial is testingAplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma PharmaMar 51
Not applicableUnknownNCT03380039What this trial is testingClinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple MyelomaWho this might be right forRefractory or Relapsed Multiple Myeloma Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT04083534What this trial is testingFirst In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)Who this might be right forRelapsed Multiple MyelomaRefractory Multiple Myeloma Regeneron Pharmaceuticals 43
Early research (Phase 1)Study completedNCT01748721What this trial is testingMORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more Morphotek 27
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Early research (Phase 1)Ended earlyNCT02110563What this trial is testingPhase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaWho this might be right forSolid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Not applicableEnded earlyNCT00062231What this trial is testingMoxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerWho this might be right forChronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Study completedNCT02363439What this trial is testingExtension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401Who this might be right forWaldenstrom's Macroglobulinemia Idera Pharmaceuticals, Inc. 5